There were 2,169 press releases posted in the last 24 hours and 346,964 in the last 365 days.

Senate Bill 1028 Printer's Number 1325

PENNSYLVANIA, January 12 - PRINTER'S NO. 1325

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

No.

1028

Session of

2024

INTRODUCED BY STREET, BARTOLOTTA, CAPPELLETTI, KEARNEY, FONTANA,

SAVAL, KANE, SANTARSIERO, LAUGHLIN, COSTA AND FLYNN,

JANUARY 12, 2024

REFERRED TO JUDICIARY, JANUARY 12, 2024

AN ACT

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

"An act relating to the manufacture, sale and possession of

controlled substances, other drugs, devices and cosmetics;

conferring powers on the courts and the secretary and

Department of Health, and a newly created Pennsylvania Drug,

Device and Cosmetic Board; establishing schedules of

controlled substances; providing penalties; requiring

registration of persons engaged in the drug trade and for the

revocation or suspension of certain licenses and

registrations; and repealing an act," further providing for

prohibited acts and penalties.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1. Section 13(a)(31) and (g) of the act of April 14,

1972 (P.L.233, No.64), known as The Controlled Substance, Drug,

Device and Cosmetic Act, are amended to read:

Section 13. Prohibited Acts; Penalties.--(a) The following

acts and the causing thereof within the Commonwealth are hereby

prohibited:

* * *

(31) Notwithstanding other subsections of this section[,]:

(i) the possession of a small amount of marihuana only for

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.